What is the significance of a urine albumin‑creatinine ratio of 74 mg/g (microalbuminuria) with normal serum creatinine, hemoglobin A1c of 5.5 % (non‑diabetic) and blood urea nitrogen of 28 mg/dL, and how should this be managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Elevated Urine Albumin-Creatinine Ratio with Normal Creatinine

This patient has moderately increased albuminuria (ACR 74 mg/g) indicating early kidney damage that requires immediate intervention with ACE inhibitor or ARB therapy and aggressive cardiovascular risk factor modification, regardless of blood pressure, even though serum creatinine remains normal. 1, 2

Clinical Significance

Your ACR of 74 mg/g falls into the "moderately increased albuminuria" category (30-299 mg/g), previously called microalbuminuria. 1, 2 This finding is critically important because:

  • Albuminuria indicates glomerular filtration barrier damage even when serum creatinine is normal, as these represent different aspects of kidney function—albumin excretion reflects barrier integrity while creatinine reflects filtration rate. 1

  • This level of albuminuria independently predicts cardiovascular events, stroke, cognitive decline, dementia, and mortality in both diabetic and non-diabetic patients, making it a powerful cardiovascular risk marker beyond just kidney disease. 1, 3

  • The slightly elevated BUN (28 mg/dL) with normal creatinine may reflect early changes in renal hemodynamics or prerenal factors, but does not negate the significance of the albuminuria. 1

  • Your HbA1c of 5.5% rules out diabetes as the cause, so this albuminuria likely reflects hypertensive nephropathy, primary glomerular disease, or vascular endothelial dysfunction. 1

Confirmation Protocol

Before establishing persistent albuminuria, you must:

  • Obtain 2 out of 3 first-morning void urine samples showing ACR ≥30 mg/g over a 3-6 month period to confirm persistence, as day-to-day variability is high. 1, 2, 3

  • Exclude transient causes that falsely elevate ACR: active urinary tract infection, fever, congestive heart failure exacerbation, marked hyperglycemia, menstruation, uncontrolled hypertension, and vigorous exercise within 24 hours. 1, 2

Immediate Management Steps

Pharmacologic Intervention

  • Start an ACE inhibitor or ARB immediately, regardless of your current blood pressure, as these agents provide specific antiproteinuric and kidney-protective effects beyond blood pressure lowering. 1, 2, 3

  • Target blood pressure <130/80 mmHg if you have hypertension. 1, 2, 3

  • Alternative agents include beta-blockers, non-dihydropyridine calcium channel blockers, or diuretics if ACE inhibitors/ARBs are contraindicated. 1

Cardiovascular Risk Reduction

  • LDL cholesterol target <120 mg/dL (or <100 mg/dL if you develop diabetes), with saturated fat intake <7% of total calories. 2, 3

  • Dietary protein restriction to 0.8 g/kg/day (the recommended daily allowance). 2

  • Weight loss if BMI >30, as obesity contributes to albuminuria progression. 3

  • Implement a low-salt, moderate-potassium diet to optimize blood pressure control. 3

Monitoring Schedule

  • Recheck ACR and calculate eGFR annually since your kidney function is currently normal (eGFR ≥60 mL/min/1.73 m²). 2

  • The therapeutic goal is to reduce ACR by at least 30-50%, ideally achieving ACR <30 mg/g, as sustained reduction in albuminuria is a validated surrogate for slowed kidney disease progression. 2

  • If ACR increases to ≥300 mg/g or eGFR declines, monitoring frequency should increase to every 3-6 months. 2

When to Refer to Nephrology

Consider nephrology referral if:

  • Rapid progression of albuminuria or decline in kidney function despite optimal therapy. 2

  • Uncertainty about the underlying cause of albuminuria in the absence of diabetes or hypertension. 2

  • eGFR falls below 30 mL/min/1.73 m². 2

  • Inadequate response to ACE inhibitor/ARB therapy after 6-12 months. 2

  • Refractory hypertension requiring ≥4 antihypertensive agents. 2

Critical Pitfalls to Avoid

  • Do not dismiss this finding because creatinine is normal—albuminuria precedes creatinine elevation by years and represents early, potentially reversible kidney damage. 1

  • Do not assume low muscle mass is causing a falsely elevated ACR—while this can occur, an ACR of 74 mg/g typically reflects true albuminuria requiring intervention. 4

  • Do not delay ACE inhibitor/ARB therapy waiting for blood pressure elevation—the kidney-protective effects are independent of blood pressure lowering. 1, 2

  • Do not use spot albumin measurement alone without creatinine correction, as this is susceptible to false results from urine concentration variations. 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Use of Creatinine in Albumin-to-Creatinine Ratio for Kidney Damage Assessment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Microalbuminuria: what is it? Why is it important? What should be done about it?

Journal of clinical hypertension (Greenwich, Conn.), 2001

Related Questions

What is the appropriate management for an adult with a urine albumin‑creatinine ratio of 45.3 mg/g (micro‑albuminuria)?
What does a urine microalbumin/creatinine ratio of 322 indicate and how is it managed?
What is the difference between microalbumin (urine albumin) and uAcr (urine albumin-to-creatinine ratio)?
What does an elevated albumin-to-creatinine ratio indicate?
What does a microalbumin/creatinine ratio of 365 indicate and how is it managed?
When should continuous renal replacement therapy be initiated in a hemodynamically unstable critically ill patient with acute kidney injury, and what are the recommended initial settings, modality selection, anticoagulation, and monitoring?
Can chronic losartan therapy cause hypokalemia in a patient with intermittent low potassium who is also taking pantoprazole, atorvastatin, apixaban, levothyroxine, clonazepam, and escitalopram?
Can we transfuse two units of packed red blood cells over two days, and what precautions are required?
In a patient with chronic kidney disease requiring treatment for active tuberculosis, how should the standard four‑drug regimen be dosed?
What is the recommended diagnostic work‑up and first‑line therapy for a 60‑year‑old woman with a rapidly enlarging painless breast mass diagnosed as primary diffuse large B‑cell lymphoma of the breast?
In an otherwise healthy adult with an isolated low‑titer positive antinuclear antibody (ANA) and no symptoms, how should this result be interpreted and managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.